These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 24544155)
21. Some considerations of cycloserine toxicity. STOREY PB; MCLEAN RL Am Rev Tuberc; 1957 Mar; 75(3):514-6. PubMed ID: 13403182 [No Abstract] [Full Text] [Related]
22. Clinical, bacteriologic, and pharmacologic observations upon cycloserine. RENZETTI AD; WRIGHT KW; EDLING JH; BUNN P Am Rev Tuberc; 1956 Jul; 74(1):128-35. PubMed ID: 13327226 [No Abstract] [Full Text] [Related]
23. A PILOT study of cycloserine toxicity; a United States Public Health Service Cooperative Clinical Investigation. Am Rev Tuberc; 1956 Aug; 74(2 Part 1):196-209. PubMed ID: 13340147 [No Abstract] [Full Text] [Related]
24. Cycloserine: antituberculous activity in vitro and in the experimental animal. STEENKEN W; WOLINSKY E Am Rev Tuberc; 1956 Apr; 73(4):539-46. PubMed ID: 13302684 [No Abstract] [Full Text] [Related]
25. [Preliminary study on the use of cycloserine in the treatment of pulmonary tuberculosis]. REBORA F; DIAZ GOMEZ ML Rev Mex Tuberc Enferm Apar Respir; 1957; 18(5):429-36. PubMed ID: 24544757 [No Abstract] [Full Text] [Related]
26. [Cycloserine, a new antibiotic, effective against tuberculosis]. HOLMDAHL SG; LIND A Nord Med; 1956 Oct; 56(42):1517-21. PubMed ID: 13388113 [No Abstract] [Full Text] [Related]
27. The convulsive effect of cycloserine. DUVALL RC; MCLEAN RL; STOREY PB Antibiotic Med Clin Ther (New York); 1956 Sep; 3(4):258-62. PubMed ID: 13355237 [No Abstract] [Full Text] [Related]
28. [Cycloserine, oxamycin, PA 94, three names for an antibiotic drug, D-4-amino-3-isoxazolidone]. PICCINELLI O Farmaco Sci; 1956; 11(7):619-29. PubMed ID: 13344530 [No Abstract] [Full Text] [Related]
29. [A new antibiotic and tuberculosis medication; cycloserine; paradoxical comparisons clinical and experimental results]. RAVINA A; PESTEL M Presse Med (1893); 1955 Nov; 63(79):1637-9. PubMed ID: 13289615 [No Abstract] [Full Text] [Related]
30. The treatment of stubborn urinary infections with a new antibiotic: cycloserine. BOAND AV; HERROLD RD; KAMP M Antibiot Annu; 1955-1956; 3():165-8. PubMed ID: 13355262 [No Abstract] [Full Text] [Related]
32. The treatment of stubborn urinary infections with a new antibiotic: cycloserine. HERROLD RD; BOAND AV; KAMP M Antibiotic Med Clin Ther (New York); 1955 Dec; 1(12):665-8. PubMed ID: 13269078 [No Abstract] [Full Text] [Related]
33. [Effect of dl-cycloserine on the nervous system]. CHERNUKH AM Antibiotiki (Mosc); 1959; 4(2):73-7. PubMed ID: 24545298 [No Abstract] [Full Text] [Related]
34. [Preliminary observations in the treatment of pulmonary tuberculosis with D-4-amino-3-isosazolidone (cycloserine)]. DADDI G; GRASSI C; CORDA M; BASILICO F G Ital Della Tuberc; 1956; 10(2):71-81. PubMed ID: 13331181 [No Abstract] [Full Text] [Related]
35. Inhibition of anitbacterial activity of cycloserine by alpha-alanine. BONDI A; KORNBLUM J; FORTE C Proc Soc Exp Biol Med; 1957 Oct; 96(1):270-2. PubMed ID: 13485077 [No Abstract] [Full Text] [Related]
36. Synthesis of L-4-amino-3-isoxazolidinone, the unnatural stereoisomer of cycloserine and its antibiotic activity. SMRT J; BERANEK J; SICHER J; SKODA J; HESS VF; SORM F Experientia; 1957 Jul; 13(7):291. PubMed ID: 13461859 [No Abstract] [Full Text] [Related]
37. [New antibiotics and pulmonary tuberculosis (viomycin, cycloserine, neomycin)]. DUMON G Mars Med; 1959; 96():619-20. PubMed ID: 13818595 [No Abstract] [Full Text] [Related]
38. Spectrophotometric determination of cycloserine and isoniazid in pharmaceutical preparations. WOODSIDE JM; PIPER I; LEARY JB J Am Pharm Assoc Am Pharm Assoc; 1957 Dec; 46(12):729-31. PubMed ID: 13491492 [No Abstract] [Full Text] [Related]
39. Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy. LEITES V Am Rev Respir Dis; 1959 Jul; 80(1, Part 1):89-94. PubMed ID: 13670395 [No Abstract] [Full Text] [Related]
40. [Studies on a possibility of clinical utilization of the synnergism between cycloserine and other antibiotics in the treatment of infections caused by staphylococci resistant to penicillin. Communication 2]. BALS M; ROMAN A; ELIAN M; NICULESCU I Antibiotiki; 1960; 5():32-5. PubMed ID: 13848050 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]